Adam and Blake Anderson from WealthGuard Advisors share their latest market update — covering the impact of the potential government shutdown, delayed employment data, and the upcoming corporate earnings season that could set the tone for the market ahead.
In this episode:
- How a government shutdown could affect the release of jobs data and the Fed’s decisions
- Why inflation remains moderate despite recent tariff effects
- The importance of upcoming earnings results to justify current market highs
- Key metrics we watch: distribution days, GDP growth, and consumer sentiment
- Stock spotlight: CRISPR Therapeutics (CRSP) — the pioneer in gene editing, with new treatments in development and technical signs of renewed strength
At WealthGuard Advisors, we focus on helping investors stay informed, diversified, and ready for market shifts.
